Analysis of a capsid-modified and conditionally replicating, oncolytic adenoviral vector as a novel treatment for human glioblastoma multiforme.
Glioblastoma multiforme (GBM) is the most aggressive brain tumor, and patients rarely survive for more than 2 years. Gene therapy may offer new treatment options and improve the prognosis for patients with GBM. Adenovirus-mediated gene therapy strategies for brain tumors have been limited by ineffic...
Sábháilte in:
Príomhchruthaitheoir: | |
---|---|
Rannpháirtithe: | |
Formáid: | Dissertation |
Teanga: | Béarla |
Foilsithe / Cruthaithe: |
Philipps-Universität Marburg
2010
|
Ábhair: | |
Rochtain ar líne: | An téacs iomlán mar PDF |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Ar líne
An téacs iomlán mar PDFGairmuimhir: |
urn:nbn:de:hebis:04-z2010-06444 |
---|---|
Dáta a fhoilsithe: |
2010-12-02 |
Foinse: |
A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models. Cancer Res. 2007 Sep 15;67(18):8783-90. PMID: 17875719 |
Datum der Annahme: |
2010-07-08 |
Downloads: |
40 (2024), 75 (2023), 100 (2022), 124 (2021), 72 (2020), 93 (2019), 48 (2018) |
Lizenz: |
https://rightsstatements.org/vocab/InC-NC/1.0/ |
URL Rochtana: |
https://archiv.ub.uni-marburg.de/diss/z2010/0644 https://doi.org/10.17192/z2010.0644 |